Expression of Concern: Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary syndrome (Gynecological Endocrinology, (1997), 11, 4, (251–257), 10.3109/09513599709152542);Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary syndrome

Gynecological Endocrinology

Volumn 11, Issue 4, 1997, Pages 251-257

  Falsetti, L ^a,b   De Fusco, D ^a   Eleftheriou, G ^a   Rosina, B ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b NONE   (Italy)

Author keywords

Finasteride; Flutamide; Hair diameter; Hirsutism; Polycystic ovary syndrome

Indexed keywords

ANDROSTENEDIONE; ANTIANDROGEN; FINASTERIDE; FLUTAMIDE; FOLLITROPIN; HYDROXYPROGESTERONE; INSULIN; LUTEINIZING HORMONE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ABDOMEN; ADULT; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FACE; FEMALE; FOLLITROPIN BLOOD LEVEL; FOREARM; HIRSUTISM; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LUTEINIZING HORMONE BLOOD LEVEL; MICROSCOPE; ORAL DRUG ADMINISTRATION; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SCORING SYSTEM; TESTOSTERONE BLOOD LEVEL; THIGH; TIME; TREATMENT OUTCOME; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRY SKIN; FEMALE SEXUAL DYSFUNCTION; GASTROINTESTINAL SYMPTOM; HAIR; HAIR ANALYSIS; HEADACHE;

EID: 0030864656     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590.2024.2429857     Document Type: Erratum

References (34)

1. Knochenhauer, E. S. and Azziz, R. (1995). Advances in the diagnosis and treatment of hirsute patients. Curr. Opin. Obstet. Gynecol., 7, 344-50
2. Barbieri, R. L. (1990). Hyperandrogenic disorders. Clin. Obstet. Gynecol., 33, 640-54
3. Maroulis, G. B. (1981). Evaluation of hirsutism and hyperandrogenemia. Fertil. Steril., 36, 273-305
4. Rittmaster, R. S. and Lorioux, D. L. (1987). Hirsutism. Ann. Intern. Med., 106, 95
5. Goldzieher, J. W. and Green, J. A. (1962). The polycystic ovary: clinical and histologic features. J. Clin. Endocrinol. Metab., 22, 325-38
6. Conway, G. S., Honour, J. W. and Jacobs, H. S. (1989). Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin. Endocrinol., 30, 459-70
7. Mauvais-Jarvis, P. (1986). Regulation of androgen receptor and 5α-reductase in the skin of normal and hirsute women. Clin. Endocrinol. Metab., 15, 307-17
8. Jenkins, E. P., Andersson, S., Imperato-McGinley, J., Wilson, J. D. and Russell, D. W. (1992). Genetic and pharmacological evidence for more than one human steroid 5α-reductase. J. Clin. Invest., 89, 293-300
9. Jahanfar, S., Eden, J. A., Warren, P., Seppala, M. and Nguyen, T. V. (1995). A twin study of polycystic ovary syndrome. Fertil. Steril., 63, 478-86
10. Lobo, R. A. (1991). Hirsutism in polycystic ovary syndrome: current concepts. Clin. Obstet. Gynecol., 34, 817-26
11. Serafini, P. C. and Lobo, R. A. (1985). Increased 5α-reductase activity in idiopathic hirsutism. Fertil. Steril., 43, 74-8
12. Paulson, R. J., Serafini, P. C., Catulino, J. A. and Lobo, R. A. (1986). Measurements of 3α, 17β-androstanediol glucuronide in serum and urine and the correlation with the skin 5α-reductase activity. Fertil. Steril., 46, 222-6
13. Roger, S. and Rittmaster, M. D. (1994). Finasteride. N. Eng. J. Med., 330 (2), 120-5
14. Brochu, M., Belanger, A., Dupont, A., Cusan, L. and Labrie, F. (1987). Effects of flutamide and aminoglutethimide on plasma 5α-reductase steroid glucuronide concentrations in castrated patients with cancer of the prostate. J. Steroid Biochem., 28, 619-22
15. Brogden, R. N. and Clissold, S. P. (1989). Flutamide: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in advanced prostatic cancer. Drugs, 38 (2), 185-203
16. Ferriman, D. and Gallwey, J. D. (1961). Clinical assessment of body hair growth in women. J. Clin. Endocrinol. Metab., 21, 1440-7
17. Adams, J., Polson, D. W., Abdolwahid, N., Morris, D. V., Franks, S., Mason, H. D., Tucker, M. and Price, J. (1985). Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet, 2, 1375-8
18. Orsini, L. F., Rizzo, N., Calderoni, O., Pilu, G. and Bovicelli, L. (1983). Ultrasound monitoring of ovarian follicular development: a comparison of real time and static scanning techniques. J. Clin. Ultrasound, 11, 207-13
19. Fruzzetti, F., De Lorenzo, D., Parrini, D. and Ricci, C. (1994). Effects of finasteride, a 5α-reductase inhibitor, on circulating androgens and gonadotropin secretion in hirsute women. J. Clin. Endocrinol. Metab., 79, 831-5
20. Wong, I. L., Morris, R. S., Chang, L., Spahn, M. A., Stanczyk, F. Z. and Lobo, R. A. (1995). A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women. J. Clin. Endocrinol. Metab., 80, 233-8
21. Marcondes, J. A. M., Minnani, S. L., Luthold, W. W., Wajchenberg, B. L., Samojlik, E. and Kirschner, M. A. (1992). Treatment of hirsutism in women with flutamide. Fertil. Steril., 57, 543-7
22. Fruzzetti, F., De Lorenzo, D., Ricci, C. and Fioretti, P. (1993). Clinical and endocrine effects of flutamide in hyperandrogenic women. Fertil. Steril., 60, 806-13
23. Marugo, M., Bernasconi, D., Meozzi, M., Del Monte, P., Zino, V., Primarolo, P. and Badaracco, B. (1994). The use of flutamide in the management of hirsutism. J. Endocrinol. Invest., 17, 195-9
24. Motta, T., Maggi, G., Perra, M., Azzolari, E., Casazza, S. and D'Alberton, A. (1991). Flutamide in the treatment of hirsutism. Int. J. Gynecol. Obstet., 36, 155-7
25. Pucci, E., Genazzani, A. D., Monzani, F., Lippi, F., Angelini, F., Gargani, M., Barletta, D., Luisi, M. and Genazzani, A. R. (1995). Prolonged treatment of hirsutism with flutamide alone in patients affected by polycystic ovary syndrome. Gynecol. Endocrinol., 9, 221-8
26. Calandra, R. S., Purvis, K., Naess, O., Attramadul, A., Djoseland, O. and Hansson, V. (1978). Androgen receptors in the rat adrenal gland. J. Steroid Biochem., 9, 1009-15
27. Bélanger, A., Labrie, F., Dupont, A., Brochu, M. and Cusan, L. (1988). Endocrine effects of combined treatment with an LHRH-agonist in association with flutamide in metastatic prostatic carcinoma. Clin. Invest. Med., 11, 321-6
28. Moghetti, P., Castello, R., Negri, C., Tosi, F., Magnani, M. M., Fontanarossa, M. C., Armanini, D. and Muggeo, M. (1995). Flutamide in the treatment of hirsutism: long-term clinical effects, endocrine changes and androgen receptor behaviour. Fertil. Steril., 64, 511-17
29. Wang, C. Y., Carmina, E., Chang, L., Wong, I. L., Stanczyk, F. Z. and Lobo, R. A. (1996). Effect of finasteride on circulating levels of insulin-like growth factors (IGFs), testosterone, dehydrotestosterone and their binding proteins in hirsute women. Presented at the 44th Annual Meeting of the Pacific Coast Fertility Society, Stouffer Esmeralda, California, April, A14
30. Imperato-McGinley, J., Gautier, T., Cai, L., Yee, B., Epstein, J. and Pochi, P. (1993). The androgen control of sebum production. Study of subjects with dehydrotestosterone deficiency and complete androgen insensitivity. J. Clin. Endocrinol. Metab., 76, 524-8
31. McKenna, T. J. (1993). Variable androgen sensitivity in relationship to hirsutism and acne. Clin. Endocrinol., 39, 547-9
32. Falsetti, L. and Pasinetti, E. (1994). Treatment of moderate and severe hirsutism by gonadotropin- releasing hormone agonists in women with polycystic ovary syndrome and idiopathic hirsutism. Fertil. Steril., 61, 817-22
33. Cusan, L., Dupont, A., Gomez, J. L., Tremblay, R. R. and Labrie, F. (1994). Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial. Fertil. Steril., 61, 281-7
34. Ciotta, L., Cianci, A., Marietta, E., Pisana, L., Agliano, A. and Palumbo, G. (1994). Treatment of hirsutism with flutamide and a low-dosage oral contraceptive in polycystic ovarian disease patients. Fertil. Steril., 62, 1129-35